These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9549136)

  • 1. [Naltrexone in the treatment of alcohol dependence].
    Ochoa Mangado E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):51-7. PubMed ID: 9549136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Naltrexone in the treatment of alcohol addiction].
    Ochoa E
    Actas Esp Psiquiatr; 2000 Dec; 28(8):37-43. PubMed ID: 11262303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.
    Volpicelli JR; Volpicelli LA; O'Brien CP
    Alcohol Alcohol; 1995 Nov; 30(6):789-98. PubMed ID: 8679021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
    Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
    Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.
    Berg BJ; Pettinati HM; Volpicelli JR
    Drug Saf; 1996 Oct; 15(4):274-82. PubMed ID: 8905252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naltrexone on human alcohol consumption.
    Swift RM
    J Clin Psychiatry; 1995; 56 Suppl 7():24-9. PubMed ID: 7673102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone in alcohol dependence.
    Hartmann PM
    Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological therapy of dependency on alcohol].
    Alho H; Hyytiä P
    Duodecim; 2009; 125(8):912-8. PubMed ID: 19492707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the use of naltrexone: an integration of preclinical and clinical findings.
    O'Malley SS; Froehlich JC
    Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.
    Prescrire Int; 1999 Feb; 8(39):9-11. PubMed ID: 10557566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A; De Sousa A
    Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone for the treatment of alcoholism.
    Ciraulo AM; Alpert N; Franko KJ
    Am Fam Physician; 1997 Sep; 56(3):803-6. PubMed ID: 9301573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes.
    Wang X; Douglas SD; Peng JS; Metzger DS; O'Brien CP; Zhang T; Ho WZ
    J Leukoc Biol; 2006 Jun; 79(6):1166-72. PubMed ID: 16574767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol.
    Mitchell JM; Bergren LJ; Chen KS; Rowbotham MC; Fields HL
    Neurobiol Dis; 2009 Jan; 33(1):72-80. PubMed ID: 18955144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.
    Oslin DW; Berrettini WH; O'Brien CP
    Addict Biol; 2006 Sep; 11(3-4):397-403. PubMed ID: 16961767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.